针治疗帕金森病中的焦虑和抑郁症:系统性审查和网络分析
Huihui Zhou1, Han Zhong2,3,4, Wenqiang Ying5
1General Hospital of Pingxiang Mining Group Co, Jiangxi, China.
Medicine
|August 13, 2025
概括
针与西方医学结合,有效地改善了帕金森病 (PD) 患者的焦虑和抑郁. 这种方法为PD的情绪症状管理提供了有希望的治疗选择.
科学领域:
- 神经学 神经学
- 综合医学是一个整体医学.
- 精神病学是一个精神病学.
背景情况:
- 帕金森病 (PD) 主要表现为运动症状,但焦虑和抑郁等情绪障碍很常见,与疾病严重程度有关.
- 针已经证明了在缓解PD患者的运动和情绪症状方面的潜力.
- 情绪症状显著影响帕金森病患者的生活质量.
研究的目的:
- 评估针在改善帕金森病 (PD) 患者焦虑和抑郁症方面的疗效.
- 为了比较各种针治疗对PD相关情绪症状的有效性.
主要方法:
- 对7个随机对照试验 (RCT) 的数据库进行了系统的文献搜索,截至2023年7月1日.
- 数据提取和选由两个独立审查员进行.
- 使用STATA 17.0和RevMan 5.4的网络和双向元分析,分别使用Cochrane手册来评估偏见.
主要成果:
- 分析了26个涉及2153名PD患者的RCT.
- 针和西方医学的联合疗法在改善汉密尔顿抑郁评分表 (HDRS),汉密尔顿焦虑评分表 (HARS) 和自我评分抑郁评分表 (SDS) 的得分方面表现出卓越的疗效.
- 与传统中医 (TCM) 和西方医学相结合的针与单独的西方医学相比,在自我评价焦虑量表 (SAS) 得分上表现出更好的改善.
结论:
- 针与西方医学结合,为帕金森病 (PD) 患者的焦虑和抑郁症管理提供了可行的治疗策略.
- 建议进一步进行高质量的研究,以验证这些发现,因为目前文献质量的现有局限性.
更多相关视频
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.8K
07:29Author Spotlight: Development of a Standardized Acupuncture Tool Inspired by Advanced Techniques for Improved Safety and Precision
Published on: January 10, 2025
397
相关概念视频
01:24Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
01:15Parkinson's Disease: Overview
704
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
704